Literature DB >> 22486601

Dose-response relationship between selective serotonin re-uptake inhibitors and injurious falls: a study in nursing home residents with dementia.

Carolyn S Sterke1, Gijsbertus Ziere, Ed F van Beeck, Caspar W N Looman, Tischa J M van der Cammen.   

Abstract

AIM: The contribution of selective serotonin re-uptake inhibitors (SSRIs) to injurious fall risk in patients with dementia has not been quantified precisely until now. Our objective was to determine whether a dose-response relationship exists for the use of SSRIs and injurious falls in a population of nursing home residents with dementia.
METHODS: Daily drug use and daily falls were recorded in 248 nursing home residents with dementia from 1 January 2006 until 1 January 2008. For each resident and for each day of the study period, data on drug use were abstracted from the prescription database, and information on falls and subsequent injuries was retrieved from a standardized incident report system, resulting in a dataset of 85,074 person-days.
RESULTS: We found a significant dose-response relationship between injurious falls and the use of SSRIs. The risk of an injurious fall increased significantly with 31% at 0.25 of the Defined Daily Dose (DDD) of a SSRI, 73% at 0.50 DDD, and 198% at 1.00 DDD (Hazard ratio = 2.98; 95% confidence interval 1.94, 4.57). The risk increased further in combination with a hypnotic or sedative.
CONCLUSIONS: Even at low doses, SSRIs are associated with increased risk of an injurious fall in nursing home residents with dementia. Higher doses increase the risk further with a three-fold risk at 1.00 DDD. New treatment protocols might be needed that take into account the dose-response relationship between SSRIs and injurious falls.
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486601      PMCID: PMC3403209          DOI: 10.1111/j.1365-2125.2011.04124.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly.

Authors:  A M Tromp; S M Pluijm; J H Smit; D J Deeg; L M Bouter; P Lips
Journal:  J Clin Epidemiol       Date:  2001-08       Impact factor: 6.437

2.  Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2001-05       Impact factor: 5.562

3.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

Review 4.  Antidepressants and body weight: a comprehensive review and meta-analysis.

Authors:  Alessandro Serretti; Laura Mandelli
Journal:  J Clin Psychiatry       Date:  2010-10       Impact factor: 4.384

5.  The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement.

Authors:  S Wood; J L Cummings; M A Hsu; T Barclay; M V Wheatley; K T Yarema; J F Schnelle
Journal:  Am J Geriatr Psychiatry       Date:  2000       Impact factor: 4.105

6.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

7.  Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries.

Authors:  Wayne A Ray; Purushottam B Thapa; Patricia Gideon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-12       Impact factor: 2.890

Review 8.  Antidepressants for treating depression in dementia.

Authors:  Jatinder Bains; Jacqueline Birks; Tom Dening
Journal:  Cochrane Database Syst Rev       Date:  2002-10-21

9.  Incidence and costs of falls and fall injuries among elderly in institutional care.

Authors:  Ilona Nurmi; Peter Lüthje
Journal:  Scand J Prim Health Care       Date:  2002-06       Impact factor: 2.581

10.  Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards.

Authors:  S J C Davies; S Eayrs; P Pratt; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

View more
  16 in total

Review 1.  Depression in cognitive impairment.

Authors:  Laurel D Pellegrino; Matthew E Peters; Constantine G Lyketsos; Christopher M Marano
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

2.  Editors' pick 2012.

Authors:  Lionel D Lewis; Andrew Somogyi; Yoon K Loke; Albert Ferro; Adam F Cohen; James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 3.  A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.

Authors:  Maryse Lapeyre-Mestre
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

Review 4.  Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.

Authors:  Torsten Kratz; Albert Diefenbacher
Journal:  Dtsch Arztebl Int       Date:  2019-07-22       Impact factor: 5.594

5.  Psychotropic Medication Use among Medicare Beneficiaries Following Traumatic Brain Injury.

Authors:  Jennifer S Albrecht; Daniel C Mullins; Gordon S Smith; Vani Rao
Journal:  Am J Geriatr Psychiatry       Date:  2016-12-28       Impact factor: 4.105

Review 6.  Pharmacologic treatment of depression in the elderly.

Authors:  Christopher Frank
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

7.  Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristics.

Authors:  Martin F Fromm; Renke Maas; Thomas Tümena; Karl-Günter Gaßmann
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

Review 8.  Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes.

Authors:  Amir A Sepehry; Philip E Lee; Ging Yuek R Hsiung; B Lynn Beattie; Claudia Jacova
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

Review 9.  Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?

Authors:  Stuart J Warden; Robyn K Fuchs
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

10.  Risk of Fractures in Older Adults with Chronic Non-cancer Pain Receiving Concurrent Benzodiazepines and Opioids: A Nested Case-Control Study.

Authors:  Ye-Jin Kang; Min-Taek Lee; Myo-Song Kim; Seung-Hun You; Jae-Eun Lee; Joo-Hyeon Eom; Sun-Young Jung
Journal:  Drugs Aging       Date:  2021-06-23       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.